Shingles Vaccine Market by Type and Geography 2024

1. Downloaded from: justpaste.it/3ab3p Shingles Vaccine Market Forecast and News 2024 Shingles Vaccine Market size has the potential to grow by USD 1.08 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period because of the steady increase in year-over-year growth. Get Sample of the Report: https://www.technavio.com/talk-to-us? report=IRTNTR41592&type=sample&src=report This report provides a detailed analysis of the market by type (recombinant vaccines and live-attenuated vaccines) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including CanSino Biologics Inc., Curevo Inc., GeneOne Life Science Inc., GlaxoSmithKline Plc, Merck & Co. Inc., SK Bioscience, and Vaccitech Ltd. Market Competitive Analysis The shingles vaccine market is concentrated and dominated by large pharmaceutical vendors that offer highly effective and safe vaccines. SK Bioscience and Vaccitech Ltd. are some of the major market participants. Although the high incidence and prevalence of shingles will offer immense growth opportunities, the side effects of shingles vaccines will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. To help clients improve their market position, this shingles vaccine market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this shingles vaccine market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities. Shingles Vaccine Market: Key Drivers and Trends The high incidence and prevalence of shingles will be a significant factor in driving the growth of the shingles vaccine market. The incidences of herpes zoster, also known as shingles, have increased rapidly over the past few decades. Shingles cause painful blistering rashes and can result in serious complications such as painful postherpetic neuralgia. The middle-aged adult population is more susceptible to shingles. It can re-occur several times during the lifetime of an individual. Hence, with increasing incidences and prevalence of shingles across the world, the demand for shingles vaccines is also expected to grow during the forecast period. The growing health awareness and improvements in healthcare services have increased life expectancy and resulted in the expansion of the geriatric population. The geriatric population is highly susceptible to shingles because of their weak immune system.

2. Aging weakens the immune system of an individual and can trigger the reactivation of the varicella-zoster virus, which leads to shingles. The expanding geriatric population is expected to increase the adoption of shingles vaccines, thereby driving the market growth. During 2020-2024, the shingles vaccine market will grow at a CAGR of over 7%. Contact us: Contact no- +91 806 191 4606 Email Id: enquiry@technavio.com